US Trade Rep Recommends Tariffs On China-Sourced Medtech, BioPharma Products

In addition to taxing foreign-made steel imports from certain countries, the US Trade Representative's office will soon recommend tariffs against Chinese-made biopharma and advanced medtech products, and other products in US/China competitive industries.

More from Archive

More from Medtech Insight